logo

Johnson & Johnson (JNJ)



Trade JNJ now with
  Date
  Headline
5/5/2018 9:57:03 AM Janssen Pharma Companies Of Johnson & Johnson Says Results From Phase 3 Clinical Studies Of Esketamine Nasal Spray
4/26/2018 10:30:09 AM Johnson & Johnson Declares 7.1% Increase In Quarterly Dividend Of $0.90/shr; Payable June 12/record May 29,
4/26/2018 10:29:00 AM Johnson & Johnson (JNJ) Declares Quarterly Dividend of $ 0.90, Record Date 5/29/2018
4/18/2018 7:46:16 AM RBC Capital Markets Is Raising Johnson & Johnson (JNJ) 4Q18 Estimate To 2.07 From 1.99
4/18/2018 7:46:05 AM RBC Capital Markets Is Cutting Johnson & Johnson (JNJ) 3Q18 Estimate To 1.97 From 2.03
4/18/2018 7:45:55 AM RBC Capital Markets Is Lowering Johnson & Johnson (JNJ) 2Q18 Estimate To 2.03 From 2.07
4/18/2018 7:45:43 AM RBC Capital Markets Is Cutting Johnson & Johnson (JNJ) 4Q18 Rev. Estimate To 20.62 Billion From 20.77 Billion
4/18/2018 7:45:33 AM RBC Capital Markets Is Cutting Johnson & Johnson (JNJ) 3Q18 Rev. Estimate To 20.20 Billion From 20.25 Billion
4/18/2018 7:45:23 AM RBC Capital Markets Is Increasing Johnson & Johnson (JNJ) 2Q18 Rev. Estimate To 20.50 Billion From 20.44 Billion
4/18/2018 7:44:57 AM RBC Capital Markets Is Cutting Johnson & Johnson (JNJ) 2019 Rev. Estimate To 83.05 Billion From 83.09 Billion
4/18/2018 7:44:45 AM RBC Capital Markets Is Increasing Johnson & Johnson (JNJ) 2018 Rev. Estimate To 81.33 Billion From 81.12 Billion
4/17/2018 6:53:36 AM Johnson & Johnson (JNJ) Has Raised Its 2018 Revenue Estimate To $81.0 - $81.8 Bln From $80.6 - $81.4 Bln
4/17/2018 6:42:08 AM Johnson & Johnson Q1 EPS $1.60 Vs $1.61 Last Year